GROBIO

We're striving to fulfill the promise of protein-based therapies by reprogramming biology. Our GRO platform creates novel proteins with an expanded alphabet of non-standard amino acids (NSAAs), providing therapeutic modalities that were previously impossible. Our production process is scalable, stable, and sustainable... GRObio's mission is to leverage the unprecedented capabilities of NSAAs in our GRO platform to overcome longstanding limitations in protein therapeutics and bring better health outcomes to patients. Our Biofoundry pairs computational protein design with sophisticated robotics, bringing sea-change acceleration to the development of NSAA therapeutics... GRObio's ProGly approach to immune tolerance has the potential to bring gene therapies to millions of patients who are currently ineligible due to pre-existing antibodies, or who cannot receive additional doses that are essential to their treatment.

Primary location: Cambridge United States